191 related articles for article (PubMed ID: 36828868)
1. Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment.
Hemminki K; Hemminki J; Försti A; Sud A
Leukemia; 2023 Apr; 37(4):854-863. PubMed ID: 36828868
[TBL] [Abstract][Full Text] [Related]
2. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
3. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
[TBL] [Abstract][Full Text] [Related]
4. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
Pulte D; Jansen L; Brenner H
Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
[TBL] [Abstract][Full Text] [Related]
5. The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies.
Sadeghi M; Khodakarami A; Ahmadi A; Fathi M; Gholizadeh Navashenaq J; Mohammadi H; Yousefi M; Hojjat-Farsangi M; Movasaghpour Akbari AA; Jadidi-Niaragh F
Expert Opin Ther Targets; 2022 Dec; 26(12):1057-1071. PubMed ID: 36683579
[TBL] [Abstract][Full Text] [Related]
6. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
7. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
[TBL] [Abstract][Full Text] [Related]
8. Age-specific survival trends and life-years lost in women with breast cancer 1990-2016: the NORDCAN survival studies.
Lundberg FE; Kroman N; Lambe M; Andersson TM; Engholm G; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Lambert PC; Mørch LS; Johansson ALV
Acta Oncol; 2022 Dec; 61(12):1481-1489. PubMed ID: 36542678
[TBL] [Abstract][Full Text] [Related]
9. Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.
Lundberg FE; Andersson TM; Lambe M; Engholm G; Mørch LS; Johannesen TB; Virtanen A; Pettersson D; Ólafsdóttir EJ; Birgisson H; Johansson ALV; Lambert PC
Acta Oncol; 2020 Nov; 59(11):1266-1274. PubMed ID: 33073632
[TBL] [Abstract][Full Text] [Related]
10. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
11. Incidence and survival of hematological cancers among adults ages ≥75 years.
Krok-Schoen JL; Fisher JL; Stephens JA; Mims A; Ayyappan S; Woyach JA; Rosko AE
Cancer Med; 2018 Jul; 7(7):3425-3433. PubMed ID: 29654631
[TBL] [Abstract][Full Text] [Related]
12. Biannual report of the Cochrane Haematological Malignancies Group.
Trelle S; Higgins G; Kober T; Engert A
J Natl Cancer Inst; 2004 Aug; 96(15):E2. PubMed ID: 15292394
[No Abstract] [Full Text] [Related]
13. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Pulte D; Gondos A; Brenner H
Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
[TBL] [Abstract][Full Text] [Related]
14. Individualizing treatment decisions for older adults with hematologic malignancies.
Klepin HD; Rizzieri D; Palumbo A; Magarotto V; Eichhorst B
Am Soc Clin Oncol Educ Book; 2013; ():208-19. PubMed ID: 23714504
[TBL] [Abstract][Full Text] [Related]
15. Risk of hematological malignancy in blood donors: A nationwide cohort study.
Zhao J; Dahlén T; Brynolf A; Edgren G
Transfusion; 2020 Nov; 60(11):2591-2596. PubMed ID: 32818321
[TBL] [Abstract][Full Text] [Related]
16. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
17. Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.
Monnereau A; Troussard X; Belot A; Guizard AV; Woronoff AS; Bara S; Lapôtre-Ledoux B; Iwaz J; Tretarre B; Maynadié M;
Int J Cancer; 2013 May; 132(10):2378-87. PubMed ID: 23034773
[TBL] [Abstract][Full Text] [Related]
18. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Huang LW; Wong SW; Andreadis C; Olin RL
Curr Oncol Rep; 2019 Mar; 21(4):35. PubMed ID: 30848394
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Treatment, and Outcome of HIV-Associated Hematologic Malignancies in People Living with HIV in Sweden.
Kieri O; Marrone G; Sönnerborg A; Nowak P
AIDS Res Hum Retroviruses; 2022 Feb; 38(2):135-142. PubMed ID: 34652958
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
